FDA backs Pfizer Covid-19 boosters for seniors, people at high risk

The ruling represents a drastically scaled back version of the Biden administration's sweeping plan to give third doses to nearly all American adults

Comments

Popular posts from this blog

Infosys lays off hundreds after failing internal assessments in Mysuru

Congress groomed me not to sit at home: Shivakumar

Greater Bengaluru Committee proposes seven municipal corporations